David Sánchez‐Martín

Author

Hospital Universitario Puerta de Hierro Majadahonda ORCID

Also Known As

D Sánchez-Martín, D. Sánchez-Martín, David Sanchez-Martin, David Sanchez‐Martin, David Snchez-Martn, David Sánchez, David Sánchez-Martín, David Sánchez‐Martín

Publications

642

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Puerta de Hierro Majadahonda Center for Cancer Research National Cancer Institute National Institutes of Health CIC bioGUNE

About

David Sánchez‐Martín is an author at Hospital Universitario Puerta de Hierro Majadahonda specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	428
2	Biomedical Engineering	5	5	246
3	Engineering	4	4	233
4	Natural Sciences	1	1	30
5	Biochemistry	1	1	30

David Sánchez‐Martín

Publications

592

Citations

H-Index

Page 1

	Year	Citations
Tumor Immunotherapy Using Gene-Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds Marta Compte, Ángel M. Cuesta, David Sánchez‐Martín, Stem Cells Tissue EngineeringCell TherapyEngineeringBiomedical EngineeringCellular Therapies	2008	96
Long-term in vivo imaging of human angiogenesis: Critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels Laura Sanz, Patricia Santos-Valle, Vanesa Alonso-Camino, Microvascular Research Tissue EngineeringRegenerative MedicineDurable Blood VesselsVivo ImagingAngiogenesis	2008	80
In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences Ángel M. Cuesta, David Sánchez‐Martín, Laura Sanz, PLoS ONE	2009	56
The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies David Sánchez‐Martín, Ángel M. Cuesta, Valentina Fogal, Journal of Biological Chemistry ImmunologyImmunotherapyTumor BiologySelective Tumor UptakeOncology	2010	41
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies David Sánchez‐Martín, Jorge L. Martínez‐Torrecuadrada, Tambet Teesalu, Proceedings of the National Academy of Sciences ImmunologyProteasomeVivo SelectionImmunotherapeuticsCancer Biology	2013	39
CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen Receptors Vanesa Alonso-Camino, David Sánchez‐Martín, Marta Compte, Molecular Therapy — Nucleic Acids Cell SynapseImmunologyImmunoeditingImmunodominanceAntigen Processing	2013	36
Tumor-Infiltrating Myeloid Cells Activate Dll4/Notch/TGF-β Signaling to Drive Malignant Progression Hidetaka Ohnuki, Kan Jiang, Dunrui Wang, Cancer Research ImmunologyCancer BiologyMyeloid CellsTumor BiologyMyeloid Neoplasia	2014	36
Improved stability of multivalent antibodies containing the human collagen XV trimerization domain Ángel M. Cuesta, David Sánchez‐Martín, Ana Blanco‐Toribio, mAbs	2012	33
Generation and characterization of monospecific and bispecific hexavalent trimerbodies Ana Blanco‐Toribio, Noelia Sainz-Pastor, Ana Álvarez‐Cienfuegos, mAbs Tissue EngineeringCombinatorial ChemistryBispecific Hexavalent TrimerbodiesEngineeringImmunology	2013	31
Addition of electrophilic lipids to actin alters filament structure Javier Machín Gayarre, David Sánchez‐Martín, Francisco J. Sánchez-Gómez, Biochemical and Biophysical Research Communications Proteinlipid InteractionBiochemistryElectrophilic LipidsNatural SciencesCell Motility	2006	30

Page 1